C3 Jian raises $30M for dental treatment

LA-based C3 Jian has raised $30 million to advance its lead peptide treatment into the clinic, testing its ability to re-mineralize teeth. The biotech, which is moving into a new facility, raised the cash from Wyssta Investments, Renaissance Health Services, and Corvesta. It is developing technology discovered at UCLA. Release

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.